期刊文献+

血浆B型钠尿肽水平对冠心病左心室收缩功能不全的诊断价值 被引量:4

The diagnostic value of B-type natriuretic peptide for left ventricular dysfunction in patients with coronary heart disease
下载PDF
导出
摘要 目的研究冠心病患者血浆B型钠尿肽(BNP)水平与左心室收缩功能的关系.方法用免疫发光法检测30名正常对照者与69例冠心病患者血浆BNP水平,通过纽约心脏病协会心功能分级标准(NYHA)及超声心动图结果对冠心病患者心功能分级.结果对照组、心功能Ⅰ~Ⅱ级组及心功能Ⅲ~Ⅳ级组的BNP水平分别为(31.56±21.48) μg/L、(105.52±91.77) μg/L和(433.18±378.03)μg/L,3组差异均有非常显著性(P<0.001).冠心病患者BNP水平与左室射血分数(LVEF)呈负相关(r=-0.70,P<0.001),其中LVEF≤40%亚组BNP水平显著高于LVEF>40%亚组(P<0.01).结论血浆BNP水平能反映冠心病患者左心室收缩功能,该指标对早期心功能不全患者的检出、心力衰竭程度的评判等具有重要的临床价值. Objective To study the relationship between the plasma level of B-type natriuretie peptide(BNP) and the left ventrieular function in patients with coronary heart disease. Methods BNP levels in plasma of 30 nomal controls and 69 patients with coronary heart disease were measured by ehemilumino-immunoassay. The ventrieular function was measured by NYHA and colored doppler eehoeardiography. Results The BNP concentrations in control group, ventrieular function ( Ⅰ - Ⅱ ) group and ventrieular function ( Ⅲ-Ⅳ ) group were ( 31.56 ± 21.48) μg/L, ( 105.52 ± 91.77) μg/L and (433.18 ± 378.03 )μg/L respectively. There was statistical significance among these groups(P 〈 0. 001 ). The levels of plasma BNP and the left ventrieular ejeetive fraction (LVEF) had a significant negative correlation (r = -0.70, P 〈0. 001 ). BNP levels of LVEF≤40% subgroup were significantly higher than those of LVEF 〉 40% subgroup (P 〈0.01 ). Conclusions BNP level reflects the left ventrieular function in patients with coronary heart disease. The determination of BNP has important value in the diagnosis of early ventrieular dysfunction and the evalua- tion of the severity of cardiac failure.
出处 《检验医学》 CAS 北大核心 2005年第5期434-436,共3页 Laboratory Medicine
关键词 B型钠尿肽 C反应蛋白 冠状动脉粥样硬化性心脏病 心功能不全 B-type natriuretie peptide C-reactive protein Coronary heart disease Cardiac failure
  • 相关文献

参考文献7

  • 1Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease[J]. Clin Sci, 1998, 95:519-529.
  • 2Kuster GM, Tanner H, Printzen G, el al. B type natriuretic peptide for diagnosis and treatment of congestive heart failure[J]. Swiss Med Wkly, 2002, 132:623-628.
  • 3Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure[J]. Circulation, 1993, 87:464-469.
  • 4Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation[J]. Am Heart J, 2002, 144:834-839.
  • 5Fischer Y, Filzmaier K, Stiegler H, et al. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide[J]. Clin Chem, 2001, 47:591-594.
  • 6Toss H, Lindahl B, Siegbahn A, et al. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease[J]. Circulation, 1997, 96:4204-4210.
  • 7Yin WH, Chen JW, Jen HL, et al. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure[J]. Am Heart J, 2004, 147:931-938.

同被引文献24

  • 1刘军锋,贾克刚,刘运德.B型钠尿肽检测在心血管疾病中的应用[J].国外医学(临床生物化学与检验学分册),2005,26(6):352-354. 被引量:25
  • 2王志刚,沈瑞林,曹浩强.慢性心力衰竭实验室诊断指标——脑钠肽的临床研究[J].国外医学(临床生物化学与检验学分册),2005,26(6):361-363. 被引量:1
  • 3王成刚,陈燕勤,胡文健.B型钠尿肽测定在心力衰竭诊断和治疗中的作用[J].检验医学,2005,20(6):526-528. 被引量:9
  • 4Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside testfor B-type peptide predicts treatment outcome in patients admitted for decompensated heart failure. J Am Coll Cardiol,2001,37 :386 -391.
  • 5Stefan KG ,Jfirgen G, Marc W, et al. Brain Natariuretic peptide predicts ritheart failure in patients with acute aulmonary embohsm. Am Heart J, 2004,147:60 - 65.
  • 6Inoue T, Sakuma M, Yanguchi I, et al. Early recanalization and plasma Brain natariuretic peptide as an indicator of leftventricular function alter acute myocardial infarction. Am Heart J ,2002,143:790 -796.
  • 7Wieczorek S J, Wu AH, Christenson R, et al. A rapid B-type Brain natariuretic peptide assay accurately diagnoses leftventricular dysfunction and heart failure: Amulticenter evaluation. Am Heart J, 2002, 144: 834 - 839.
  • 8Cheng V,Kazanagra R,Garcia A,et al.A rapid bedside testfor B-type peptide predicts treatmentoutcome in patients admitted fordecompensated heart failure[J].J Am Coll Cardiol,2001,37:386-391.
  • 9Stefan KG,Jfirgen G,Marc W,et al.Brain Natariuretic peptide predicts ritheart failure in patientswith acute aulmonary embolism[J].Am Heart J,2004,147:60-65.
  • 10Inoue T,Sakuma M,Yanguchi I,et al.Early recanalization and plasma Brain natariuretic peptide as an indicator of leftventricular function afteracutemyocardial infarction[J].Am Heart J,2002,143:790-796.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部